PURPOSE: We tried to clarify the cytotoxic mechanism of VK(3) using the breast cancer cell line MCF-7. METHODS: Cytotoxicity was measured via intracellular esterase activity. DNA fragmentation was assessed by agarose gel electrophoresis. JC-1 staining was applied to measure mitochondrial dysfunction. Caspase activation and reactive oxidative species (ROS) generation were also measured. RESULTS: VK(3) exhibited cytotoxicity that caused DNA fragmentation in MCF-7 cells with an IC(50) of 14.2 microM. JC-1 staining revealed that VK(3) caused mitochondrial dysfunction including a disappearance of mitochondrial membrane potential. Additional investigation showed that the mitochondrial damage was induced by the generation of ROS and the subsequent activation of caspase-7 and -9. CONCLUSIONS: Our findings demonstrate that VK(3)-induced apoptosis is selectively initiated by the mitochondria-related pathway and might be useful in breast cancer chemotherapy.
PURPOSE: We tried to clarify the cytotoxic mechanism of VK(3) using the breast cancer cell line MCF-7. METHODS:Cytotoxicity was measured via intracellular esterase activity. DNA fragmentation was assessed by agarose gel electrophoresis. JC-1 staining was applied to measure mitochondrial dysfunction. Caspase activation and reactive oxidative species (ROS) generation were also measured. RESULTS: VK(3) exhibited cytotoxicity that caused DNA fragmentation in MCF-7 cells with an IC(50) of 14.2 microM. JC-1 staining revealed that VK(3) caused mitochondrial dysfunction including a disappearance of mitochondrial membrane potential. Additional investigation showed that the mitochondrial damage was induced by the generation of ROS and the subsequent activation of caspase-7 and -9. CONCLUSIONS: Our findings demonstrate that VK(3)-induced apoptosis is selectively initiated by the mitochondria-related pathway and might be useful in breast cancer chemotherapy.
Authors: Dmitry V Semenov; Alexander S Fomin; Elena V Kuligina; Olga A Koval; Vera A Matveeva; Irina N Babkina; Nina V Tikunova; Vladimir A Richter Journal: Protein J Date: 2010-04 Impact factor: 2.371
Authors: Kevin W Wellington; Vincent Hlatshwayo; Natasha I Kolesnikova; Sourav Taru Saha; Mandeep Kaur; Lesetja R Motadi Journal: Invest New Drugs Date: 2019-11-07 Impact factor: 3.850
Authors: Kevin W Wellington; Natasha I Kolesnikova; Vincent Hlatshwayo; Sourav T Saha; Mandeep Kaur; Lesetja R Motadi Journal: Invest New Drugs Date: 2019-04-27 Impact factor: 3.850
Authors: Zahid M Delwar; Dimitrios Avramidis; Elna Follin; Yan Hua; Åke Siden; Mabel Cruz; Kajsa M Paulsson; Juan Sebastian Yakisich Journal: Invest New Drugs Date: 2011-05-10 Impact factor: 3.850